Search results
Results From The WOW.Com Content Network
Ashley Gandy, 39, who lives in Carrollton, Texas, takes Vyvanse for her ADHD, a prescription she got through a telehealth doctor. Her 6-year-old son takes Concerta, which his pediatrician prescribes.
More than 6 million children in the U.S. have been diagnosed with ADHD, one of the most common neurodevelopmental disorders, according to the Centers for Disease Control and Prevention.Millions of ...
Vyvanse, also known as lisdexamfetamine, is classified by the DEA as a schedule II controlled substance, which is applied to drugs considered to have a high likelihood of being abused, and ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. [16] Lisdexamfetamine is taken by mouth. Its effects generally begin within two hours ...
Variability in the ADHD prevalences of children in China can be attributed to differences in study methodology, socioeconomics, and dates of data collection. [14] The prevalence of ADHD diagnosis in China could be explained by the one-child rule that had affected China's population, and thus could have had psychological effects on children ...
Data released by the U.S. Centers for Disease Control and Prevention in May showed that 1 million more kids and adolescents in the U.S. received an ADHD diagnosis — 7.1 million kids total — in ...
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...